Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia

Shih-Lung ChengRen-Guang WuYin-Ching ChuangWann-Cherng PerngShih-Ming TsaoYu-Ting ChangLi-Wen ChangMing-Chu Hsu2026-01-302026-01-302019-1010.1016/j.jmii.2018.11.006https://scholars.csmu.edu.tw/handle/123456789/3887[SDGs]SDG3Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumoniajournal-article